Skip to content
This search input has a predictive search function. When 3 letters or more are entered, a number of predictive results appear in a dropdown. Use arrow keys to navigate and use the enter key to go to the page highlighted.
    RENEW JOIN
    Dashboard

    Alexander Gralnick, M.D. Award for Research in Schizophrenia

    APA Foundation invites submissions for The Alexander Gralnick, M.D. Award for Research in Schizophrenia annually in the fall.

    Named after the late Alexander Gralnick, M.D., the award acknowledges research achievements in the treatment of schizophrenia, emphasizing early diagnosis and treatment and psychosocial aspects of the disease process.

    Program Benefits

    $3,000

    Criteria / Eligibility

    Additional preference will be given to researchers working in a psychiatric facility.

    Nomination / Application Details

    • A statement summarizing the nature of his or her research relevant to the award, emphasizing its internal consistency and scientific implications
    • A list of publications (or articles accepted for publication) relevant to the award
    • An up-to-date Curriculum Vitae
    • An up-to-date bibliography

    The application may be emailed in PDF format to Cierra Williams at [email protected], using "Alexander Gralnick Application" as the subject line.

    Deadline

    September 30

    Award Presentation

    Presented at an APA Meeting

    Contact

    Cierra Williams
    [email protected]

    Award Notification

    An expert committee in the field of schizophrenia research will confer the award. The award and lecture are presented at the Institute on Psychiatric Services (IPS) meetings in October. All applications will be acknowledged, but will not be returned. The award is based upon a bi-annual competition; resubmission is permitted and encouraged.

    The American Psychiatric Association Foundation is a 501(C)(3) organization. An endowment for this award was provided by the Gralnick Foundation in memory of Dr. Alexander Gralnick's work and interest in the field of schizophrenia.

    Medical leadership for mind, brain and body.

    Join Today